These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6237539)

  • 1. Effects of 40 mcg. and 400 mcg. of ipratropium bromide in obstructive lung disease.
    Dejaegher P; Demedts M; Rochette F; Van der Veken J
    Acta Clin Belg; 1984; 39(3):136-40. PubMed ID: 6237539
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
    Easton PA; Jadue C; Dhingra S; Anthonisen NR
    N Engl J Med; 1986 Sep; 315(12):735-9. PubMed ID: 2943994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose ipratropium bromide--is it safe?
    Leak A; O'Connor T
    Practitioner; 1988 Jan; 232(1441):9-10. PubMed ID: 2975378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Function studies of an atropine derivative--ipratropium bromide in an aerosol device--in patients with chronic obstructive bronchopneumopathies].
    Mairesse M; Ledent C
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):196-9. PubMed ID: 162192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant bronchodilator therapy and ipratropium bromide. A clinical review.
    Chervinsky P
    Am J Med; 1986 Nov; 81(5A):67-73. PubMed ID: 2947463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ipratropium bromide and salbutamol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Aust N Z J Med; 1981 Oct; 11(5):513-6. PubMed ID: 6459776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the method of inhalation of Berodual on bronchodilation in patients over 60 years of age with diffuse bronchial obstruction].
    Czernicka-Cierpisz E; Kościńska M; Radomyski A; Sliwiński P; Zieliński J
    Pneumonol Pol; 1988 Oct; 56(10):486-91. PubMed ID: 2978275
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticholinergic block of allergic bronchospasm in bronchial asthma].
    Abrosimov VN; Brukmaĭerova MR
    Ter Arkh; 1978; 50(3):22-6. PubMed ID: 148746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of ipratropium bromide in aerosol administration on airway resistance and MEFV curves].
    Illiano A; Tranfa CM; Giacomelli P; Cantatore D; Donato Di Paola RM; Marsico SA
    Arch Monaldi; 1981; 36(3):105-17. PubMed ID: 6216870
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.
    Ruffin RE; Newhouse MT
    Lung; 1978; 155(2):141-6. PubMed ID: 149884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
    Stauder J; Flasch CI
    Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
    [No Abstract]   [Full Text] [Related]  

  • 13. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE; Archer PS; Cayton RM
    Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
    Brown IG; Chan CS; Kelly CA; Dent AG; Zimmerman PV
    Thorax; 1984 Apr; 39(4):272-6. PubMed ID: 6232724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ingram RH
    Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipratropium bromide and fenoterol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Br J Clin Pharmacol; 1982 Jul; 14(1):113-5. PubMed ID: 6213250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction.
    Maesen FP; Smeets JJ; Bernsen R; Cornelissen PJ
    Allergy; 1986 Jan; 41(1):37-42. PubMed ID: 2938515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Atrovent administered by inhalation on pulmonary mechanics in patients with obstructive lung disease [proceedings].
    Koch G
    Scand J Respir Dis Suppl; 1979; 103():206-7. PubMed ID: 155300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.